Related Experiment Video
Updated: Mar 23, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Myocardial apoptosis in heart disease: does the emperor have clothes?
J Jose Corbalan1, Dorothy E Vatner1, Stephen F Vatner2
1Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, Newark, NJ, 07103, USA.
Insights
Apoptosis, programmed cell death, significantly impacts heart conditions. Research has overlooked non-myocyte apoptosis, crucial for understanding heart attack and heart failure severity.
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Cardiac Pathophysiology
Background:
- Apoptosis (programmed cell death) is recognized for its role in myocardial infarction and heart failure.
- The majority of heart cells are non-myocytes, yet research predominantly focuses on myocyte apoptosis.
- Existing studies on myocardial apoptosis largely neglect the contribution of non-myocyte cell death.
Purpose of the Study:
- To review the historical research on apoptosis in the heart, differentiating between myocyte and non-myocyte apoptosis.
- To highlight the understudied role of non-myocyte apoptosis in myocardial infarction and heart failure.
- To stimulate future research into the mechanisms of non-myocyte apoptosis in cardiac disease.
Main Methods:
- Literature review focusing on apoptosis in cardiac cells.
- Historical analysis of research trends in myocyte versus non-myocyte apoptosis.
- Synthesis of evidence implicating non-myocyte apoptosis in heart conditions.
Main Results:
- Historically, research on cardiac apoptosis has disproportionately focused on myocytes, neglecting the majority cell population.
- Non-myocyte apoptosis (cardiac fibroblasts, endothelial cells, smooth muscle cells, immune cells) may significantly influence myocardial infarction and heart failure outcomes.
- A substantial gap exists in understanding the specific mechanisms of non-myocyte apoptosis in cardiac pathology.
Conclusions:
- The prevailing focus on myocyte apoptosis in cardiac research is a significant oversight.
- Non-myocyte apoptosis is likely a critical, yet under-explored, determinant of heart disease severity.
- Further investigation into non-myocyte apoptosis is essential for a comprehensive understanding of cardiac apoptosis and for developing effective therapeutic strategies.
Abstract:
Since the discovery of a novel mechanism of cell death that differs from traditional necrosis, i.e., apoptosis, there have been numerous studies concluding that increased apoptosis augments myocardial infarction and heart failure and that limiting apoptosis protects the heart. Importantly, the vast majority of cells in the heart are non-myocytes with only roughly 30 % myocytes, yet almost the entire field studying apoptosis in the heart has disregarded non-myocyte apoptosis, e.g., only 4.7 % of 423 studies on myocardial apoptosis in the past 3 years quantified non-myocyte apoptosis. Accordingly, we reviewed the history of apoptosis in the heart focusing first on myocyte apoptosis, followed by the history of non-myocyte apoptosis in myocardial infarction and heart failure. Apoptosis of several of the major non-myocyte cell types in the heart (cardiac fibroblasts, endothelial cells, vascular smooth muscle cells, macrophages and leukocytes) may actually be responsible for affecting the severity of myocardial infarction and heart failure. In summary, even though it is now known that the majority of apoptosis in the heart occurs in non-myocytes, very little work has been done to elucidate the mechanisms by which non-myocyte apoptosis might be responsible for the adverse effects of apoptosis in myocardial infarction and heart failure. The goal of this review is to provide an impetus for future work in this field on non-myocyte apoptosis that will be required for a better understanding of the role of apoptosis in the heart.
Related Concept Videos
Pathophysiology of Heart Failure
Apoptosis
Myocarditis I: Introduction
The Intrinsic Apoptotic Pathway
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Extrinsic Apoptotic Pathway

